No. 7 / 2025 Resolutions from Zealand Pharma's Annual General Meeting 2025 Copenhagen, Denmark, March 27, 2025 - Zealand ...

No. 6 / 2025 Zealand Pharma major shareholder announcement: Van Herk Investments B.V. Copenhagen, Denmark, March 25, 2025 – ...

Morgan Stanley analyst Laura Hindley upgraded Zealand Pharma (ZLDPF) to Overweight from Equal Weight with a DKK 750 price target The ...

Copenhagen, Denmark, March 20, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide ...

Detailed price information for Zealand Pharma A/S (ZLDPF) from The Globe and Mail including charting and trades.

Check Out Our Latest Analysis on ZLDPF Zealand Pharma A/S Stock Performance Zealand Pharma A/S stock opened at $84.50 on Friday. The stock’s 50-day moving average is $97.35 and its 200-day ...

(Repeats Feb 16 story with no changes to text) By Medha Singh and Manas Mishra (Reuters) - U.S.-based Eli Lilly (NYSE:LLY) and... By Medha Singh and Manas Mishra (Reuters) - U.S.-based Eli Lilly ...

Overview: Zealand Pharma A/S is a biotechnology company focused on discovering, developing, and commercializing peptide-based medicines in Denmark and the United States, with a market capitalization ...

Roche (RHHBY) is increasing its investment into the obesity space with an up to $5.3 billion deal with Danish drugmaker Zealand Pharma (ZLDPF), the companies announced Wednesday. The deal would give ...